News Focus
News Focus
Followers 12
Posts 2415
Boards Moderated 0
Alias Born 12/31/2020

Re: HyGro post# 809876

Saturday, 01/17/2026 7:40:07 AM

Saturday, January 17, 2026 7:40:07 AM

Post# of 823013

You seem to have missed that ECA control arms require PRE-TRIAL design and mutual agreement. NWBO initiated their ECA control virtually POST-TRIAL, announced two weeks before data lock. It's why they aren't having FDA review, because it violated FDA's guidelines. Let's see if MHRA violates their new guidance with the DCVax-L



Don't know what is so hard to understand about this. Nwbo trial failed and they tried some gymnastics instead of admitting failure and redesigning a new trial. Effing simple. This trial as it stands is not apprpvable by any regulatory agency.....they saw the loopholes on the UK PROCESS so they applied here first. If they applied to the FDA, the FDA would have rejected them within the initial confirmation. 2 plus years in and people thinking there is still hope for the UK submission. Lmfao. There might be a final pump on this and if you are a true retail holder you better gtfo on that pump if it ever comes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News